A randomized, placebo-controlled, dose-escalation study to determine the safety, tolerability, and immunogenicity of an HPV-16 therapeutic vaccine in HIV-positive participants with oncogenic HPV infection of the anus. (Q43297040)
Jump to navigation
Jump to search
scientific article published in November 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, placebo-controlled, dose-escalation study to determine the safety, tolerability, and immunogenicity of an HPV-16 therapeutic vaccine in HIV-positive participants with oncogenic HPV infection of the anus. |
scientific article published in November 2009 |
Statements
A randomized, placebo-controlled, dose-escalation study to determine the safety, tolerability, and immunogenicity of an HPV-16 therapeutic vaccine in HIV-positive participants with oncogenic HPV infection of the anus (English)
Jonathan S Anderson
Richard Hillman
Megan Barnden
Beng Eu
Andrew McKenzie
Charmaine Gittleson